<DOC>
	<DOCNO>NCT00797758</DOCNO>
	<brief_summary>Multicentric evaluation reduction unrelated cord blood transplantation ( UCBT ) toxicity use reduce intensity conditioning ( RIC ) patient acute myeloid leukaemia.UCBT relate mortality morbidity limit factor development procedure adult . Non myeloablative conditioning regimen show promising result prospective evaluation develop confirm retrospective data .</brief_summary>
	<brief_title>Reduction Cord Blood Transplantation Toxicity Patients With Acute Myeloid Leukemia</brief_title>
	<detailed_description>Individual meta-analysis plan compare geno-identical transplantation myeloid-ablative non myeloid-ablative conditioning UCBT RIC .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>Ages : 4 65 De novo secondary AML require allogeneic transplant No donor ( relate unrelated ) compatible 10/10 Complete remission except CR1 ( 8 ; 21 ) inv ( 16 ) ( 15 ; 17 ) Smouldering AML without progression Signed assent recipient If CR1 : AML ( 8 ; 21 ) inv ( 16 ) ( 15 ; 17 ) Karnofsky &lt; 50 % Clearance creatinin &lt; 40 ml/min Transaminases &gt; 8 N Previous autologous allogeneic transplantation within 6 month prior study ( except tandem ) total body irradiation contraindicate 2 Gy TBI local irradiation contraindicate 2 Gy TBI</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Cord blood transplantation</keyword>
	<keyword>Conditioning regimen</keyword>
	<keyword>Acute myeloid leukaemia</keyword>
	<keyword>SORROR comorbidity index</keyword>
	<keyword>Quality life</keyword>
	<keyword>Innate immunity</keyword>
	<keyword>Immune reconstitution post transplant</keyword>
	<keyword>Umbilical Cord Blood Stem Cell Transplantation</keyword>
	<keyword>Hematopoietic Stem Cell Transplantation</keyword>
</DOC>